Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Novartis
AstraZeneca
Acrivon Therapeutics
Artios Pharma Ltd
Ensem Therapeutics
Eli Lilly and Company
AstraZeneca
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Faeth Therapeutics
AstraZeneca
Johns Hopkins University
VA Office of Research and Development
Johns Hopkins University
Totus Medicines
Simons Searchlight
Sanford Health
Assistance Publique - Hôpitaux de Paris
Zhuhai Yufan Biotechnologies Co., Ltd